Keywords: Acute coronary syndromes; Acute myocardial infarction; Antithrombotic therapy; Antithrombotics; Emergency medical system; Evidence; Fibrinolysis; Guidelines; Ischaemic heart disease; MINOCA; Primary percutaneous coronary intervention; Quality indicators; Reperfusion therapy; Risk assessment; ST-segment elevation; Secondary prevention.